National Institute on Aging; Notice of Closed Meeting, 55816-55817 [2014-22133]
Download as PDF
<![CDATA[
mstockstill on DSK4VPTVN1PROD with NOTICES
55816
Federal Register / Vol. 79, No. 180 / Wednesday, September 17, 2014 / Notices
FDA will post a notice closing
registration at https://www.fda.gov/
TobaccoProducts/NewsEvents/
ucm238308.htm. If you need special
accommodations due to a disability,
please contact Caryn Cohen (see Contact
Person) no later than December 3, 2014.
Presenters and Panelists: FDA is
interested in gathering scientific
information from individuals with a
broad range of perspectives on technical
topics to be discussed at the workshop.
To be considered to serve as a presenter,
please provide the following:
• A brief abstract for each
presentation. The abstract should
identify the specific topic(s) to be
addressed and the amount of time
requested.
• A one-page biosketch that describes
and supports the speaker’s scientific
expertise on the specific topic(s) being
presented, nature of the individual’s
experience and research in the scientific
field, positions held, and any program
development activities.
Panelists will sit on a panel to discuss
their scientific knowledge on the
questions and presentations in each
session. To be considered to serve as a
panelist, please provide the following:
• A one-page biosketch that describes
and supports the speaker’s scientific
expertise on the specific topic(s) being
presented, nature of the individual’s
experience and research in the scientific
field, positions held, and any program
development activities.
If you are interested in serving as a
presenter or panelist, please submit the
above information, along with the topic
on which you would like to speak, to
workshop.CTPOS@fda.hhs.gov by
November 4, 2014.
Oral Presentations by Members of the
Public: This workshop includes a public
comment session. Persons wishing to
present during the public comment
session must make this request at the
time of registration and should identify
the topic they wish to address from
among those topics under consideration,
which are identified in section II. FDA
will do its best to accommodate requests
to present. FDA urges individuals and
organizations with common interests to
consolidate or coordinate their
comments, and request a single time for
a joint presentation. For those requesters
with Internet access, Caryn Cohen (see
Contact Person) will email you
regarding your request to speak by
November 26, 2014.
Transcripts: A transcript of the
proceedings will be available after the
workshop at https://www.fda.gov/
TobaccoProducts/NewsEvents/
ucm238308.htm as soon as the official
transcript is finalized. It will also be
VerDate Sep<11>2014
18:24 Sep 16, 2014
Jkt 232001
posted to the docket at https://
www.regulations.gov once the docket is
opened.
SUPPLEMENTARY INFORMATION:
I. Background
FDA is announcing a public
workshop to gather scientific
information and stimulate discussion
among scientists about electronic
cigarettes (e-cigarettes). The focus of this
workshop will be product science
(specifically device designs and
characteristics, and e-liquid and aerosol
constituents), product packaging,
constituent labeling, and environmental
impact. FDA intends to follow this
workshop with two additional
workshops that will address other
scientific topics related to e-cigarettes,
including: (1) The impact of e-cigarettes
on individual health, including clinical
pharmacology, topography, abuse
liability, dependence, and health effects
and (2) the impact of e-cigarettes on the
population, including discussions of
product appeal (e.g., impact of
advertising, marketing, flavorings,
consumer perceptions) and product
safety labeling.
On April 25, 2014, FDA published a
proposed rule to extend its tobacco
product authorities to additional
products that meet the statutory
definition of ‘‘tobacco product’’
(Deeming Tobacco Products to Be
Subject to the Federal Food, Drug, and
Cosmetic Act, as Amended by the
Family Smoking Prevention and
Tobacco Control Act; Regulations on the
Sale and Distribution of Tobacco
Products and Required Warning
Statements for Tobacco Products; 79 FR
23141, April 25, 2014, Docket No. FDA–
2014–N–0189) (proposed deeming rule).
If the proposed deeming rule is finalized
as proposed, e-cigarettes that are
tobacco products would be subject to
FDA regulation under the FD&C Act. As
stated in the proposed deeming rule,
FDA ‘‘is aware of the recent significant
increase in the prevalence in e-cigarette
use’’ (79 FR 23141 at 23152), and there
is much to be learned about these
relatively new entrants to the market.
These workshops are intended to
better inform FDA about these products.
Should the Agency move forward as
proposed to regulate e-cigarettes,
additional information about the
products would assist the Agency in
carrying out its responsibilities under
the law. This would be true regardless
of the details of any such final rule.
Accordingly, FDA is working to obtain
such information now rather than
waiting for the conclusion of the
deeming rulemaking.
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
Participants should note that this
workshop is not intended to inform the
Agency’s deeming rulemaking. All
comments regarding the proposed
deeming rule were to be submitted to
the Agency by August 8, 2014 (Docket
No. FDA–2014–N–0189). As such, the
scope of this workshop is limited to the
topics presented in Section II.
At the start of this first workshop in
this series, FDA will announce via a
Federal Register notice the
establishment of a docket for
submission of written comments.
Regardless of attendance at the public
workshops, interested persons will be
invited to submit comments to the
docket. The forthcoming Federal
Register notice will provide information
on how to submit comments. Please
note that this docket will only pertain
to this workshop. Comments submitted
to the docket will not be added to other
dockets, such as the docket for the
proposed rule deeming additional
tobacco products subject to the FD&C
Act.
II. Topics for Discussion
The public workshop will include
presentations and panel discussion
regarding e-cigarettes and the public
health, specifically relating to the
products themselves. Topics to be
addressed include, for example: (1)
Product science (including design,
chemistry, and toxicology); packaging,
labeling, and environmental impact
assessments; (2) potential risks and
benefits of product characteristics; (3)
strategies to mitigate risk to users; (4)
methods for evaluating product
performance, constituents, stability, etc.;
and (5) potential risks to the
environment. Additional information
related to workshop presentations and
discussion topics, including specific
questions to be addressed at the
workshop, can be found at https://
www.fda.gov/TobaccoProducts/
NewsEvents/ucm238308.htm.
Dated: September 11, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014–22122 Filed 9–16–14; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
E:\FR\FM\17SEN1.SGM
17SEN1
Federal Register / Vol. 79, No. 180 / Wednesday, September 17, 2014 / Notices
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To Review And Evaluate Grant
Applications.
Place: National Institute on Aging,
Gateway Building, Suite 2C212, 7201
Wisconsin Avenue, Bethesda, Md 20892,
(Telephone Conference Call).
Contact Person: Jeannette L. Johnson,
Ph.D., National Institutes on Aging, National
Institutes of Health, 7201 Wisconsin Avenue,
Suite 2C212, Bethesda, MD 20892, 301–402–
7705, JOHNSONJ9@NIA.NIH.GOV.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Name of Committee: National Institute on
Aging Special Emphasis Panel; ADCC.
Date: October 15, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda,
(Formerly Holiday Inn Select), 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Ramesh Vemuri, Ph.D.,
Chief, Scientific Review Branch, National
Institute on Aging, National Institutes of
Health, 7201 Wisconsin Avenue, Suite 2C–
212, Bethesda, MD 20892, 301–402–7700,
rv23r@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: September 11, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
Dated: September 11, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–22133 Filed 9–16–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on DSK4VPTVN1PROD with NOTICES
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Energy and
Aging.
Date: November 17, 2014.
VerDate Sep<11>2014
18:24 Sep 16, 2014
Jkt 232001
[FR Doc. 2014–22131 Filed 9–16–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Rodent
Colony Pathology Monitoring Contract.
Date: October 8, 2014.
Time: 3:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute on Aging,
Gateway Building, Suite 2C212, 7201
Wisconsin Avenue, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Bita Nakhai, Ph.D.,
Scientific Review Branch, National Institute
On Aging, Gateway Bldg. 2C212, 7201
Wisconsin Avenue, Bethesda, MD 20814,
301–402–7701, nakhaib@nia.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
55817
Dated: September 11, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–22132 Filed 9–16–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Cancer Institute Council of
Research Advocates.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Cancer
Institute Council of Research Advocates.
Date: October 21, 2014.
Time: 9:00 a.m. to 3:30 p.m.
Agenda: NCI Update, How Advocates Can
Advance Cancer Immunotherapy Research,
Distress Screening, Working Group
Discussion.
Place: National Institutes of Health, 31
Center Drive, Building 31, C-Wing,
Conference Rooms 6 & 8, Bethesda, MD
20892.
Contact Person: Kelley Landy, NCI Office
of Advocacy Relations, National Cancer
Institute, 31 Center Drive, Building 31, Room
10A28, Bethesda, MD 20892, 301–594–3194,
Kelley.landy@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page:
deainfo.nci.nih.gov/advisory/ncra/ncra.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
E:\FR\FM\17SEN1.SGM
17SEN1
]]>Agencies
[Federal Register Volume 79, Number 180 (Wednesday, September 17, 2014)]
[Notices]
[Pages 55816-55817]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-22133]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
[[Page 55817]]
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Aging Special Emphasis
Panel; ADCC.
Date: October 15, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree Hotel Bethesda, (Formerly Holiday Inn Select),
8120 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Ramesh Vemuri, Ph.D., Chief, Scientific Review
Branch, National Institute on Aging, National Institutes of Health,
7201 Wisconsin Avenue, Suite 2C-212, Bethesda, MD 20892, 301-402-
7700, rv23r@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging
Research, National Institutes of Health, HHS)
Dated: September 11, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-22133 Filed 9-16-14; 8:45 am]
BILLING CODE 4140-01-P
